C-Reactive Protein Is a Predictor for Developing Proteinuria in a Screened Cohort

Background: The relationship between C-reactive protein (CRP) and proteinuria is not known. Methods: We examined 20,077 screenees (men: 52.4%) of the Okinawa General Health Maintenance Association (OGHMA) registry who were examined between 2004 and 2006. Cross-sectional and longitudinal relationships between CRP and dipstick proteinuria were examined. The OGHMA central laboratory measured creatinine and CRP levels using an autoanalyzer (normal: <0.30 mg/dl). The glomerular filtration rate was estimated using the Japanese formula. Results: The prevalence of dipstick-positive proteinuria increased from 5.2% in screenees with a low CRP level of <0.10 mg/dl to 12.3% in those with high CRP levels (0.30–0.90 mg/dl). The CRP values did not affect the mean (SD) estimated glomerular filtration rate: 76.9 (13.7) with low CRP and 76.4 (15.1) with high CRP levels. We examined the relationship between baseline CRP and the development of proteinuria among subjects screened in 2004. Of 8,315 subjects without proteinuria examined again by 2006, 370 (4.4%) had developed proteinuria. The odds ratio (95% CI) for high CRP levels (0.30–0.90 mg/dl; reference CRP: <0.10 mg/dl) was 1.433 (1.013–2.028; p = 0.0422) after adjusting for multivariate variables, suggesting that CRP is closely associated with the prevalence and incidence of proteinuria. Conclusion: A prospective study on the development of proteinuria among those with high CRP levels is warranted. Screenees with high CRP levels may need to be followed up carefully despite the absence of traditional risk factors for proteinuria.

[1]  Charles E McCulloch,et al.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.

[2]  B. Caballero,et al.  Association between obesity and kidney disease: a systematic review and meta-analysis. , 2008, Kidney international.

[3]  K. Iseki,et al.  Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  K. Iseki,et al.  Metabolic Syndrome and Risk of Developing Chronic Kidney Disease in Japanese Adults , 2007, Hypertension Research.

[5]  Bertram L Kasiske,et al.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. , 2003, Hypertension.

[6]  S. Bakker,et al.  Metabolic aspects of dietary sodium restriction as a therapeutic intervention , 2010 .

[7]  M. Kubo,et al.  Metabolic syndrome and CKD in a general Japanese population: the Hisayama Study. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  Yasuhiko Tomino,et al.  Revised equations for estimated GFR from serum creatinine in Japan. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  I. Kubota,et al.  Prevalence and risk factor analysis of microalbuminuria in Japanese general population: the Takahata study. , 2006, Kidney international.

[10]  T. Sairenchi,et al.  Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. , 2007, Kidney international.

[11]  G. Remuzzi,et al.  Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? , 1990, Kidney international.

[12]  J. Griffith,et al.  Inflammation and cardiovascular events in individuals with and without chronic kidney disease. , 2008, Kidney international.

[13]  K. Iseki.  Chronic kidney disease in Japan. , 2008, Internal medicine.

[14]  K. Iseki.  Chronic Kidney Disease in Japan from Early Predictions to Current Facts , 2008, Nephron Clinical Practice.

[15]  K. Fushimi,et al.  An Overview of Regular Dialysis Treatment in Japan (as of 31 December 2004) , 2006, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[16]  D. Tsikas,et al.  Chronic angiotensin II receptor blockade reduces (intra)renal vascular resistance in patients with type 2 diabetes. , 2005, Journal of the American Society of Nephrology : JASN.

[17]  V. D’Agati,et al.  Obesity-related glomerulopathy: an emerging epidemic. , 2001, Kidney international.

[18]  K. Iseki.  The okinawa screening program. , 2003, Journal of the American Society of Nephrology : JASN.

[19]  S. Ito,et al.  Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient , 2007, Clinical and Experimental Nephrology.

[20]  K. Iseki,et al.  Proteinuria and the risk of developing end-stage renal disease. , 2003, Kidney international.

[21]  C. Wanner,et al.  Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. , 1999, Kidney international.

[22]  K. Iseki.  Screening for renal disease--what can be learned from the Okinawa experience. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[23]  K. Iseki,et al.  Risk of developing end-stage renal disease in a cohort of mass screening. , 1996, Kidney international.

[24]  A. Okayama,et al.  Association between serum C-reactive protein levels and microalbuminuria: a population-based cross-sectional study in northern Iwate, Japan. , 2004, Internal medicine.

[25]  G. Remuzzi,et al.  Role of remission clinics in the longitudinal treatment of CKD. , 2008, Journal of the American Society of Nephrology : JASN.